Angle shares storm north on Parsortix lung cancer result
Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix.
Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix.
Parsortix, which specialises in medical diagnostics, has confirmed its cell separation device can "capture cultured lung cancer cells". This comes after previous announcements indicating the technology can identify breast and prostate cancer cells.
According to Cancer Research UK, women have a lifetime risk of 12.5% of suffering breast cancer (6.1% up to the age of 64) and men have a 12.1% risk of suffering prostate cancer (2.3% up to the age of 64).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
![https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748-320-80.jpg)
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Lung cancer is the next most prevalent, and therefore most likely to generate revenues. Men have a 7.5% lifetime risk of getting it, for women the figure is 5.5%.
Current diagnostic technology usually relies on so called "antibody affinity capture" to locate cancer cells. This method is, according to Angle, not always effective.
Parsortix's separation method could be used to diagnose and monitor cancer patients more quickly and reliably.
Angle says, however, that there are a number of phases to go through before full production, including confirming separation can capture types and cancer while also getting the device certified by independent experts.
Nevertheless the effect on Angle's share price has been dramatic, it is up 10% this morning, 294% on the year to date.
Angle owns 90% of Parsortix.
BS
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Regulator moves to protect access to cash amid branch closures and disappearing ATMs
News The Financial Conduct Authority has told banks to start assessing if local communities have adequate cash access from mid-September
By Marc Shoffman Published
-
VAT hike on private school fees could come earlier than previously expected
The government could start charging VAT on private school fees as soon as January 2025, according to the latest reports. What does it mean for parents?
By Katie Williams Published